431979-47-4 - Names and Identifiers
431979-47-4 - Physico-chemical Properties
Molecular Formula | C22H21ClN2O5
|
Molar Mass | 428.87 |
Density | 1.27±0.1 g/cm3(Predicted) |
Boling Point | 560.8±60.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
Appearance | powder |
Color | orange |
pKa | -0.30±0.40(Predicted) |
Storage Condition | Sealed in dry,2-8°C |
In vitro study | The p53 pathway is disrupted in virtually every human tumor. SJ-172550 binds the p53-binding pocket of MDMX, thereby displacing p53. SJ-172550 binds reversibly to MDMX and effectively kills retinoblastoma cells in which the expression of MDMX is amplified. The effect of SJ-172550 is additive when combined with an MDM2 inhibitor nutlin-3a. SJ-172550 acts through a complicated mechanism in which the compound forms a covalent but reversible complex with MDMX and locks MDMX into a conformation that is unable to bind p53. The relative stability of this complex is influenced by many factors including the reducing potential of the media, the presence of aggregates. |
431979-47-4 - Risk and Safety
Hazard Symbols | Xn - Harmful
|
Risk Codes | 22 - Harmful if swallowed
|
WGK Germany | 3 |
431979-47-4 - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 2.332 ml | 11.659 ml | 23.317 ml |
5 mM | 0.466 ml | 2.332 ml | 4.663 ml |
10 mM | 0.233 ml | 1.166 ml | 2.332 ml |
5 mM | 0.047 ml | 0.233 ml | 0.466 ml |
Last Update:2024-01-02 23:10:35
431979-47-4 - Reference Information
biological activity | SJ-172550 is a small molecule inhibitor of MDMX; the EC50 value of competitive binding to MDMX with wild-type p53 peptide is 5 μM. |
target | IC50: 5 μM (MDMX) |
in vitro study | The p53 pathway is disrupted in virtually every human tumor. SJ-172550 binds the p53-binding pocket of MDMX, thereby displacing p53. SJ-172550 binds reversibly to MDMX and effectively kills retinoblastoma cells in which the expression of MDMX is amplified. The effect of SJ-172550 is additive when combined with an MDM2 inhibitor nutlin-3a. SJ-172550 acts through a complicated mechanism in which the compound forms a covalent but reversible complex with MDMX and locks MDMX into a conformation that is unable to bind p53. The relative stability of this complex is influenced by many factors including the reducing potential of the media, the presence of aggregates. |
Last Update:2024-04-09 21:54:55